Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03015870 · ClinicalTrials.gov registry record · NA

Technology-assisted Vocal Exercise for Older Adults

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT03015870: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.

NCT03015870 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03015870, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

Many detrimental effects of aging have been identified in the human voice, most of which are accepted as "normal". However, age-related vocal deficits disrupt communication and decrease quality of life in older adults and may be preventable and/or treatable through behavioral interventions. The objective of this proposal is to determine the effectiveness of a technology-assisted vocal exercise intervention on the vocal function and quality of life in older adults. Forty older adults (65+) will be recruited and randomly assigned to either an app or PDF-delivered vocal training intervention lasting 8 weeks. Pre- and post-testing involving vocal functioning assessments, as well as mobility, psychosocial, and cognitive functioning assessments will be conducted. This interdisciplinary project will enhance the investigators understanding of physical, mental, and social health-related quality of life among older adults.

Primary Outcome

Dysphonia Severity Index: composite measure of maximum phonation time (s), highest fundamental frequency (Hz), lowest intensity (dB) and jitter (%).

Interventions

  • BEHAVIORAL Vocal exercise with real-time feedback
  • BEHAVIORAL Vocal exercise with recording

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2014-09
Est. Completion 2016-12
Phase NA

What the finished NCT03015870 record still lists

NCT03015870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Vocal exercise with real-time feedback is the first listed.

NCT03015870 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03015870 about?

NCT03015870 is a clinical study titled "Technology-assisted Vocal Exercise for Older Adults". Many detrimental effects of aging have been identified in the human voice, most of which are accepted as "normal". However, age-related vocal deficits disrupt communication and decrease quality of life in older adults and may be preventable and/or treatable through behavioral interventions. The obje...

What is the current status of trial NCT03015870?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-09. Estimated completion is 2016-12.

What interventions are being tested in trial NCT03015870?

The interventions under investigation include: Vocal exercise with real-time feedback (BEHAVIORAL), Vocal exercise with recording (BEHAVIORAL).

Who is sponsoring clinical trial NCT03015870?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03015870's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03015870, the US trial registry maintained by the National Library of Medicine. NCT03015870 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.